Recurrent Lung Adenocarcinoma

specific

The reemergence of lung adenocarcinoma after a period of remission.

53

Centers

23

Active Trials

Cancer Funding

Top Centers for Recurrent Lung Adenocarcinoma(53)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
63.7
2
NCI Comprehensive
Active Research Program
63.7
3
NCI Comprehensive
Active Research Program
63.7
4
NCI Comprehensive
Active Research Program
63.7
5
NCI Comprehensive
Active Research Program
63.7
6
NCI Comprehensive
Active Research Program
63.7
763.7
8
NCI Comprehensive
Active Research Program
63.7
9
NCI Comprehensive
Active Research Program
63.7
10
NCI Comprehensive
Active Research Program
63.7
11
NCI Comprehensive
Active Research Program
63.7
12
NCI Clinical
Active Research Program
63.7
13
NCI Comprehensive
Active Research Program
63.7
14
Active Research Program
63.7
15
NCI Comprehensive
Active Research Program
63.7
16
NCI Clinical
Active Research Program
63.7
17
Active Research Program
63.7
18
Active Research Program
63.7
19
Active Research Program
63.7
20
Active Research Program
63.7
21
Active Research Program
63.7
22
Active Research Program
63.7
23
Active Research Program
63.7
24
NCI Comprehensive
41.2
25
NCI Comprehensive
41.2
2641.2
27
NCI Comprehensive
41.2
28
NCI Comprehensive
41.2
2941.2
3041.2
31
NCI Comprehensive
41.2
32
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
41.2
33
NCI Comprehensive
41.2
34
NCI Comprehensive
41.2
35
NCI Comprehensive
41.2
36
NCI Comprehensive
41.2
3741.2
3841.2
3941.2
40
NCI Comprehensive
41.2
4141.2
4241.2
4341.2
44
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
41.2
45
NCI Comprehensive
41.2
4641.2
4741.2
48
NCI Basic_laboratory
41.2
4941.2
5041.2
5141.2
5241.2
5341.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →